Abstract:Objective To investigate the clinical efficacy of gonadotropin-releasing hormone (GnRH-α) assisted laparoscopy in the treatment of moderate and severe endometriosis and its expression on 5-lipoxygenase (5-LOX) and lipoxin A4 (LXA4). Methods Totally 78 patients with endometriosis who were treated at the Second Affiliated Hospital of Zhengzhou University from 2014 to 2017 were randomly included in the observation group (laparoscopic GnRH-α) and the control group (laparoscopic alone). The differences of VAS scores, clinical efficacy, sex hormone levels and 5-LOX and LXA4 levels were compared between the two groups before and after treatment. Results In the observation group, the intraoperative blood loss, the first exhaust time and the time of hospitalization were lower than those of the control group, and the effect of relieving chronic pelvic pain, dysmenorrhea and sexual intercourse was better than that of the control group. (P < 0.05). In addition, treatment efficiency of the observation group (84.6%) was higher than the control group (61.5%), and the sex hormone level (FSH, LH, E2) was improved after the treatment group. The expression of LXA4 (439.5 ± 48.3 pg/ml) in the observation group was significantly higher than that in the control group (152.4 ± 15.5 pg/ml, 367.1 ± 42.4 pg/ml) (P < 0.05). Conclusion GnRH-α helps to improve the level of expression of 5-LOX and LXA4 and regulates the level of sex hormones, thereby improving the therapeutic effect of laparoscopy in endometriosis.